Academic Journal
Advancing Mental Health Provision in Pharmacy (AMPLIPHY)
| العنوان: | Advancing Mental Health Provision in Pharmacy (AMPLIPHY) |
|---|---|
| المؤلفون: | Gorton, H C, Riste, L, Armitage, C J, Ashcroft, D M |
| المصدر: | Gorton , H C , Riste , L , Armitage , C J & Ashcroft , D M 2021 , ' Advancing Mental Health Provision in Pharmacy (AMPLIPHY) ' , International Journal of Pharmacy Practice , vol. 29 , no. Supplement_1 , pp. i43-i44 . https://doi.org/10.1093/ijpp/riab015.053 |
| سنة النشر: | 2021 |
| الوصف: | Introduction Improvement of mental health is a priority in the NHS Long Term Plan (1), and pharmacists and their teams could provide enhanced support for people who take medicines for anxiety or depression, two of the most common mental health problems in the UK. However, a recent Cochrane review (2) identified no community pharmacy services focused on mental health. Aim We aimed to pilot a mental health support service, in community pharmacy: Advancing Mental Health Provision in Pharmacy (AMPLIPHY) to assess its feasibility and potential benefit. Methods The AMPLIPHY service was codesigned through a workshop involving people with lived experience, pharmacists and researchers. The resultant programme is a series of consultations, beginning at the presentation of the qualifying prescription for an antidepressant, after a further 1–2 weeks and then as further prescriptions are presented, up to 3 months. People are eligible to enter the service if they are newly prescribed antidepressants for depression or anxiety, or have a change in medication, dose or quantity. Pharmacists and their teams identified people who met this criterion and invited them to participate. The service was intended to be patient-led, with the pharmacist helping the patient to define tangible aims and/or outcomes that they wanted to focus on, and providing sign-posting where required. Following brief one-day training, the pilot ran across ten pharmacies in Greater Manchester from November 2019 through March 2020. We triangulated results from: a) quantitative analysis of consultation data; b) content analysis of consultation records; and c) template analysis of semi-structured interviews with participating pharmacists at the start and end of the service. We aimed to obtain feedback from people on exit from the AMPLIPHY service, but this was curtailed due to the coronavirus pandemic. Consultations were recorded via the Pharm outcomes system (a,b) and interviews were recorded and transcribed, with NVivo used to manage the interview dataset (c). ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/ijpp/riab015.053 |
| الاتاحة: | https://pure.hud.ac.uk/en/publications/2e1c8b43-b00a-4d07-9ff1-2a35ff85ba6c https://doi.org/10.1093/ijpp/riab015.053 |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.A8C85FD2 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/ijpp/riab015.053 |
|---|